Articles published by Xenon Pharmaceuticals Inc.

< Previous 1 2 3 4 Next >

Xenon Pharmaceuticals Provides Update on Partnered Program with Neurocrine Biosciences

November 09, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

November 08, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate Update

November 01, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Announces Publication of Results from XEN1101 Phase 2b “X-TOLE” Clinical Trial in Peer-Reviewed Journal Article in JAMA Neurology

October 09, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro Summit

October 06, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual Novel Mechanisms in Neuropsychiatry Summit

September 14, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Announces Upcoming Investor Webinar with Leading Key Opinion Leaders to Discuss XEN1101 and Major Depressive Disorder

September 12, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at 35th International Epilepsy Congress

September 04, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Present at the Wells Fargo 2023 Healthcare Conference

August 31, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 09, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Expands Leadership on its Board of Directors with Appointments of Gillian M. Cannon and Justin Gover

August 08, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Second Quarter 2023 Financial Results and Provide Corporate Update

August 02, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

June 06, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Present at the 2023 Jefferies Healthcare Conference

May 31, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Present at the 2023 RBC Capital Markets Global Healthcare Conference

May 11, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

May 09, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2023

May 03, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Corporate Update

May 02, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Showcases Its XEN1101 Epilepsy Program at the 2023 American Academy of Neurology (AAN) Annual Meeting

April 24, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

April 21, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference

April 18, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Present at the Stifel 2023 CNS Days

March 22, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

March 01, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update

February 22, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference

February 08, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2023

January 09, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 04, 2023

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2022)

December 02, 2022

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Present at the Bank of America Securities Biotech SMID Cap Conference 2022

November 30, 2022

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences

November 09, 2022

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

< Previous 1 2 3 4 Next >

Articles published by Xenon Pharmaceuticals Inc.

Starting at /week.